Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Natale Imbesi"'
Autor:
Pierpaolo Correale, Valerio Nardone, Pierpaolo Pastina, Pierosandro Tagliaferri, Luigi Pirtoli, Rita Emilena Saladino, Rocco Giannicola, Rita Agostino, Nicoletta Staropoli, Alessandra Strangio, Teresa Del Giudice, Maria Altomonte, Paolo Tini, Antonia Consuelo Falzea, Natale Imbesi, Valentina Arcati, Giuseppa Romeo, Daniele Caracciolo, Amalia Luce, Michele Caraglia, Antonio Giordano, Alois Necas, Evzen Amler, Vito Barbieri, Pierfrancesco Tassone
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Nivolumab is a human monoclonal antibody against programmed cell death receptor-1 (PD-1) able to rescue quiescent tumor infiltrating cytotoxic T lymphocytes (CTLs) restoring their ability to kill target cells expressing specific tumor anti
Externí odkaz:
https://doaj.org/article/903b06629eeb4b71bbf87b7168ef20f5
Autor:
Giuseppa Romeo, Rita Agostino, Daniele Caracciolo, Natale Imbesi, Pierfrancesco Tassone, Amalia Luce, Luigi Pirtoli, Alois Nečas, Pierpaolo Correale, Rocco Giannicola, Teresa Del Giudice, Nicoletta Staropoli, Evzen Amler, Pierosandro Tagliaferri, Vito Barbieri, Alessandra Strangio, Pierpaolo Pastina, Rita Emilena Saladino, M. Altomonte, Valerio Nardone, Diana Giannarelli, Paolo Tini, Valentina Arcati, Antonio Giordano, Antonia Consuelo Falzea, Michele Caraglia
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundNivolumab is a human monoclonal antibody against programmed cell death receptor-1 (PD-1) able to rescue quiescent tumor infiltrating cytotoxic T lymphocytes (CTLs) restoring their ability to kill target cells expressing specific tumor antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1905deaf39a4611f9d4981936aae8b4
https://doi.org/10.1136/jitc-2020-000733
https://doi.org/10.1136/jitc-2020-000733